Cochrane Abstracts
Haloperidol discontinuation for people with schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Discontinuation for People With Schizophrenia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia.
Haloperidol discontinuation for people with schizophrenia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia. Accessed December 4, 2024.
Haloperidol discontinuation for people with schizophrenia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia
Haloperidol Discontinuation for People With Schizophrenia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol discontinuation for people with schizophrenia
ID - 433050
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
